Newsletter

Ziopharm Receives FDA Clearance for IND with the National Cancer Institute

Ziopharm Oncology (ZIOP) announced on June 11 that the FDA approved an investigational new drug (IND) application as part of a research and development project the company has with the National Cancer Institute. They will now begin clinical trials in solid tumors to evaluate T-cell receptor (TCR) T-cell therapy that uses Ziopharm’s Sleeping Beauty platform. […]

Read more...

May 2019 Scorecard

The May 2019 scorecard for the signals generated from Sonal can be downloaded here. For more information regarding how you can trade these signals, see the article The Three Moves for Event Based Trading Try Sonal 30 days for free and cancel anytime! Subscribe here and check out the Quickstart Guide FacebookGoogle+Twitter

Read more...

La Jolla Pharmaceutical Announces Positive Phase 2 Results of LJPC-401

On June 6, La Jolla Pharmaceutical Company (LJPC) announced positive clinical trial results from its Phase 2 study of LJPC-401. This was a pre-specified interim analysis of its synthetic human hepcidin in patients with hereditary hemochromatosis (HH). Patients experienced statistically significant efficacy levels and tolerated the drug well.   Sonal detected the news event and […]

Read more...

AMSC Awarded Contract with Ingalls Shipbuilding

On May 13, AMSC (AMSC) announced that the company received a contract award from Huntington Ingalls Industries through its Ingalls Shipbuilding division. Under the terms of the contract, AMSC will provide a high temperature conductor-based ship protection system for the San Antonio class of amphibious transport dock ship. The system reduces the magnetic signature of the […]

Read more...

April 2019 Scorecard

The April 2019 scorecard for the signals generated from Sonal can be downloaded here. For more information regarding how you can trade these signals, see the article The Three Moves for Event Based Trading Try Sonal 30 days for free and cancel anytime! Subscribe here and check out the Quickstart Guide FacebookGoogle+Twitter

Read more...